GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iCo Therapeutics Inc (FRA:0IT) » Definitions » FCF Yield %

iCo Therapeutics (FRA:0IT) FCF Yield % : 0.00 (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is iCo Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, iCo Therapeutics's Trailing 12-Month Free Cash Flow is €-0.07 Mil, and Market Cap is €11.06 Mil. Therefore, iCo Therapeutics's FCF Yield % for today is 0.00%.

The historical rank and industry rank for iCo Therapeutics's FCF Yield % or its related term are showing as below:


FRA:0IT's FCF Yield % is not ranked *
in the Biotechnology industry.
Industry Median: -14.39
* Ranked among companies with meaningful FCF Yield % only.

iCo Therapeutics's FCF Margin % for the quarter that ended in Mar. 2021 was 0.00%.


iCo Therapeutics FCF Yield % Historical Data

The historical data trend for iCo Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iCo Therapeutics FCF Yield % Chart

iCo Therapeutics Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.25 -3.68 -1.86 -1.61 -0.51

iCo Therapeutics Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.52 -0.50 -0.73 -0.22 0.33

Competitive Comparison of iCo Therapeutics's FCF Yield %

For the Biotechnology subindustry, iCo Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iCo Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iCo Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where iCo Therapeutics's FCF Yield % falls into.



iCo Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

iCo Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2020 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.581 / 113.77352
=-0.51%

iCo Therapeutics's annualized FCF Yield % for the quarter that ended in Mar. 2021 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0.18 * 4 / 220.92126
=0.33%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iCo Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


iCo Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of iCo Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


iCo Therapeutics (FRA:0IT) Business Description

Traded in Other Exchanges
N/A
Address
777 Hornby Street, 6th Floor, Vancouver, BC, CAN, V6Z 1S4
iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between the cells of the immune system. Geographically, it operates in Canada and Australia.

iCo Therapeutics (FRA:0IT) Headlines

No Headlines